WaferGen Bio-systems to Announce Third Quarter 2015 Financial Results on Tuesday, November 10

FREMONT, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS) announced today that it will announce third quarter ended September 30, 2015 financial results after the market close and host a conference call and webcast on Tuesday, November 10, 2015.

Conference Call & Webcast
Tuesday, November 10th @ 5pm Eastern:
Domestic: 877-407-3982
International: 201-493-6780
Conference ID: 13622196
Webcast: http://public.viavid.com/player/index.php?id=116585
Replays, available through November 24:
Toll-Free: 877-870-5176
International: 858-384-5517
Conference ID: 13622196

About WaferGen

WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.

CONTACT: INVESTOR CONTACTS: LifeSci Advisors, LLC Brian Ritchie BRitchie@LifeSciAdvisors.com WaferGen Bio-systems, Inc. Rollie Carlson Rollie.Carlson@wafergen.com

Source:WaferGen Bio-systems, Inc.